Australia, Feb. 18 -- Amgen Inc., owns the trademark (2503781) for 'BEMTUVIQ' till Dec. 3, 2034.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of gastric and gastro-esophageal diseases, conditions or maladies; other pharmaceutical preparations.] and 5 [Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders;pharmaceutical preparations and substances for the treatment of oncological diseases and disorders;pharmaceutical p...